A phase 2 randomized, double-blind trial of ART-001, a selective PI3Kα inhibitor, for the treatment of slow-flow vascular malformations
M. Ozeki, Akira Tanaka, Kanako Kuniyeda, T. Nozaki, Akihiro Fujino, T. Nomura, Naoto Uemura, Souichi Suenobu, N. Aramaki-Hattori, A. Hayashi, Aiko Kato, H. Kiyosue, Kotaro Imagawa, Munetomo Nagao, Fumiaki Shimizu, J. Ochi, S. Horiuchi, T. Ohyama, Haruhi Ando, Hiroshi Nagabukuro
Orphanet Journal of Rare Diseases